West Pharmaceutical Services, Inc. WST

370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

West Pharmaceutical Services, Inc. (WST) P/E ratio

As of 25 September 2026, West Pharmaceutical Services, Inc. (WST) trades at a P/E ratio of 47.1×. Over the past ten years it has ranged from 24.7× (November 2022) to 74.4× (September 2020); the current reading is higher than 61% of that period. That is above the Medical Instruments & Supplies industry median of 34.2× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 40.3× (16.99%)
FY2024 48.5× 11.06%
FY2023 43.7× 46.70%
FY2022 29.8× (43.35%)
FY2021 52.6× (12.96%)
FY2020 60.4× 31.40%
FY2019 46.0× 31.31%
FY2018 35.0× (27.87%)
FY2017 48.5× 13.16%
FY2016 42.9× (5.27%)

Quarterly

Period P/E ratio Change
Jun 2026 45.6× 36.86%
Mar 2026 33.3× (17.26%)
Dec 2025 40.3× 4.27%
Sep 2025 38.6× 18.66%
42 more quarters

Against its own ten years

Low 24.7× High 74.4×
Ten-year median 44.3×
Current reading's percentile 61

P/E ratio against peers

Company P/E ratio
BAX Baxter International Inc. compare n/m
SOLV Solventum Corporation compare 10.9×
COO The Cooper Companies, Inc. compare 18.9×
RMD ResMed Inc. compare 21.3×
WST West Pharmaceutical Services, Inc. 47.1×
ALC Alcon compare 49.2×
BDX Becton, Dickinson and Company compare 55.4×
RGEN Repligen Corporation compare 253×
MDLN Medline Inc. compare —
Medical Instruments & Supplies industry median 34.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on WST